Catalyst Financial Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318K Sell
4,502
-77
-2% -$5.76K 0.04% 282
2025
Q4
$361K Buy
4,579
+16
+0.4% +$1.27K 0.04% 223
2025
Q3
$376K Buy
4,563
+6
+0.1% +$472 0.05% 206
2025
Q2
$366K Buy
4,557
+265
+6% +$20.4K 0.04% 207
2025
Q1
$345K Sell
4,292
-1
-0% -$83 0.06% 194
2024
Q4
$352K Buy
4,293
+91
+2% +$7.57K 0.07% 182
2024
Q3
$347K Buy
4,202
+23
+0.6% +$1.72K 0.07% 182
2024
Q2
$293K Buy
4,179
+189
+5% +$13.5K 0.06% 189
2024
Q1
$275K Buy
3,990
+151
+4% +$10.5K 0.07% 187
2023
Q4
$254K Sell
3,839
-777
-17% -$48.6K 0.07% 186
2023
Q3
$290K Buy
4,616
+495
+12% +$30.8K 0.09% 157
2023
Q2
$233K Buy
4,121
+183
+5% +$10.2K 0.08% 170
2023
Q1
$228K Sell
3,938
-186
-5% -$12.6K 0.1% 159
2022
Q4
$298K Buy
+4,124
New +$295K 0.15% 111

Other funds holding MET

Catalyst Financial Partners's MET Position: Q1 2026 in Review

Catalyst Financial Partners reduced its MetLife (MET) stake by 1.7% in Q1 2026, selling an estimated $5.76K and leaving 4,502 shares worth $318K. The position accounts for 0.04% of the portfolio, ranked #282.

Catalyst Financial Partners first reported a position in MET in Q4 2022 and has held it in 14 quarters since. The position peaked at $376K in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Catalyst Financial Partners held 4,502 shares of MetLife worth $318K as of Q1 2026.
  • Catalyst Financial Partners sold 77 MetLife shares in Q1 2026, an estimated $5.76K.
  • MetLife made up 0.04% of Catalyst Financial Partners's portfolio in Q1 2026, its #282 holding.
  • Catalyst Financial Partners first reported a position in MetLife in Q4 2022 and has held it in 14 quarters since.
  • Catalyst Financial Partners's MetLife position peaked at $376K in Q3 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Catalyst Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.